id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_xai5uteqojdvlerxixyal7mgqm	John L. Wagner	Engraftment and Immune Recovery (IR) in Good Risk Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Two Different Approaches Using Cyclophosphamide (CY) for T-Cell Tolerization	2014	2	.pdf	application/pdf	2341	218	66	Engraftment and Immune Recovery (IR) in Good Risk Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Two Different Approaches Using Cyclophosphamide (CY) for T-Cell Tolerization patients (214, 83%) received antiviral therapy within a median of 3 days (range, 0d e 28d) after onset of first symptom. Methods: Case series study for thalassemia and hemoglobinopathy patients undergoing HCT at Bangkok Hospital We developed a 2 step haploidentical HSCT where 76 patients received myeloablative or reduced intensity regimens occurrence of day 0 in the 2 step group, the median time to STEM CELL Transplant Patients: A Case Series occurs in approximately one-half of patients following allogeneic hematopoietic stem cell transplant (HSCT). Engraftment and Immune Recovery (IR) in Good Risk Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): Compa ... END Organ Disease in the Context of Human Herpes VIRUS 6 Viremia in Pediatric Allogeneic Hematopoietic STEM CELL Transplant ...	./cache/work_xai5uteqojdvlerxixyal7mgqm.pdf	./txt/work_xai5uteqojdvlerxixyal7mgqm.txt